ClinicalTrials.gg
Sign In

Adenoma, Islet Cell clinical trials

The registry lists 113 studies for Adenoma, Islet Cell across more than 10 countries. 30 are recruiting or about to start. 53 of them are mainly about Adenoma, Islet Cell (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its narrower condition Insulinoma too: 158 studies, 38 open.

Get an email when these change. Save the Adenoma, Islet Cell studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
43
Recruiting
24
Active, not recruiting
14
Status unknown
14
Terminated
9
Not yet recruiting
3

Phase

Phase 2
42
Phase 1
18
Phase 3
5
Phase 4
1
Early Phase 1
1

Where

United States
59
China
20
France
12
Italy
11
Netherlands
10
Spain
7

Who runs them

Fudan University (5) · Dana-Farber Cancer Institute (5) · National Cancer Institute (NCI) (4) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (3) · M.D. Anderson Cancer Center (2) · Changhai Hospital (2) · Ohio State University Comprehensive Cancer Center (2) · Roswell Park Cancer Institute (2)

What is being tested here

Drugs under test in Adenoma, Islet Cell studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Temozolomide205
Everolimus105
Sunitinib104
Capecitabine103
Lutetium Lu 177 dotatate102
SVN53-67/M57-KLH peptide vaccine102
PM 01183101
Nimotuzumab101
Belzutifan101
Zanzalintinib111

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 2 open · Alkylating agents 2 open · Angiogenesis inhibitors 1 open · Antimetabolites 1 open

Coming up

4phase 3 studies under way
18studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 24 Adenoma, Islet Cell studies recruiting now, 17 (71%) set no upper age limit and 2 (8%) stop at 75 or younger. 2 (8%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (13%) take healthy volunteers.

Recruiting studies that take each age, of 24
AgeWomenMen
100 (0%)0 (0%)
1824 (100%)24 (100%)
3024 (100%)24 (100%)
4024 (100%)24 (100%)
5024 (100%)24 (100%)
6524 (100%)24 (100%)
7524 (100%)24 (100%)
8519 (79%)19 (79%)

Across all 113 studies, recruiting or not: 7% stop at 75 or younger and 2% at 65; 10% take children; 1% are for women only and 1% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Adenoma, Islet Cell studies take

Of 17 phase 2 interventional studies under Adenoma, Islet Cell, half reached primary completion within 70 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 270 mo33–72 · 17 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 113. Browse all 113 → or search them.